EARLY GOOD LATER BETTER. RELATIONSHIP OF BCR-ABL LEVEL AT 12 MONTHS OF TARGET THERAPY WITH INDIVIDUAL CHARACTERISTICS OF MOLECULAR RESPONSE IN EARLY TREATMENT PERIOD IN CHRONIC MYELOID LEUKEMIA

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	741-741
Number of pages	1
Journal	Haematologica
Volume	101
State	Published - Jun 2016
Event	21st Congress of the European-Hematology-Association - Copenhagen, Denmark Duration: 9 Jun 2016 → 12 Jun 2016

ID: 61329476